LRCX vs NEPH · P/E 71, rev $23.23B vs P/E 48, rev $11.2M
Lam Research Corp (LRCX) versus Nephros Inc (NEPH) — a side-by-side from cached financials, not a winner call.
Lam Research Corp (LRCX) is a semiconductor equipment & materials company listed on NASDAQ.
Nephros Inc (NEPH) is a medical instruments & supplies company listed on US.
Latest reported LRCX revenue for 2026-06-28 was $23.23B. Net income was $7.27B. Revenue was up 26.0% from 2025-06-29 to 2026-06-28. LRCX currently screens at market cap $467.94B and trailing P/E 70.9.
Latest reported NEPH revenue for 2026-06-30 was $11.2M. Net income was $1.3M. NEPH currently screens at market cap $40.9M and trailing P/E 48.3.
LRCX currently screens at market cap $467.94B and trailing P/E 70.9. NEPH currently screens at market cap $40.9M and trailing P/E 48.3.
Not investment advice. Open the LRCX and NEPH stock pages for the full models.
Not investment advice.